Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention

Clinical trial NCT07318103 · RECRUITING

Trial details

NCT number: NCT07318103
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fluid Retention Caused by Heart Failure

Start date: 2025-12-31
Primary completion: 2026-07-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.